Sign in
AMAM Stock Price, Chart, Stats & News
Ambrx Biopharma Inc.
Save
1.77B
Market cap
66.67x
Current P/E
–
Forward P/E
AMAM chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 100.00% |
Operating margin | -771.16% |
Pretax margin | -1027.55% |
Net margin | -1053.72% |
Effective tax rate | -2.55% |
ROA | -53.07% |
ROE | -50.68% |
D/E | 0.10x |
Interest coverage ratio | -58.97x |
AMAM valuation
P/E | 66.67x |
P/S | 239.41x |
P/B | 9.17x |
P/CF | -15.74x |
P/FCF | -25.41x |
P/OCF | -15.74x |
PEG | -0.14x |
EV multiple | -28.74x |
About
Ambrx Biopharma Inc. operates as a clinical-stage biotechnology company focused on the discovery and development of precisely engineered biologic medicines. The firm utilizes its unique expanded genetic code technology platform to create these advanced therapies. Leading its pipeline is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is currently undergoing evaluation in several clinical investigations.
Similar securities
Based on sector and market capitalization
Report issue